Skip to main content Accessibility help
×
Home
  • Print publication year: 2021
  • Online publication date: January 2021

Chapter 16 - Eosinophils and Neutrophils

from Section V - Leucocyte Disorders

Summary

Eosinophilia in neonates is identified when the blood concentration of eosinophils exceeds the upper reference range limit. To avoid the potential pitfall of laboratory or technician error, perhaps the definition should be two subsequent eosinophil counts above the upper reference limit. The 95th percentile for blood concentration of eosinophils increases slightly over the first month following birth. Initially a count ≥1,200/µL would exceed the upper range, and by about four weeks a count of above 1,500/µL would exceed the upper limit [1]. This latter value is similar to that generally used to define eosinophilia in adults [2]. Adults with persistent eosinophilia are well advised to have the situation evaluated, because an association has been seen between persistent eosinophilia and end-organ damage [2]. Some adults with persistent eosinophilia have elevated blood Interkeukin-5 (IL-5) concentrations [3]. Some with hypereosinophilic syndrome have an eosinophilic leukemia involving a translocation in the tyrosine kinase gene [4].

Related content

Powered by UNSILO
1.Christensen, RD, Jensen, J, Maheshwari, A, Henry, E. Reference ranges for blood concentrations of eosinophils and monocytes during the neonatal period defined from over 63,000 records in a multihospital health-care system. J Perinatol 2010;30(8):540–5.
2.McCurley, TL, Greer, JP. Diagnostic approach to malignant and nonmalignant disorders of the phagocytic and immune systems. In Greer, JP, Foerster, J, Rodgers, GM, et al. eds. Wintrobe’s Clinical Hematology (Philadelphisa PA: Lippincott/Williams & Wilkins: 2009), pp. 1513–14.
3.Simon, HU, Plotz, SG, Dummer, R, et al. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341(15):1112–20.
4.Gotlib, J. Molecular classification and pathogenesis of eosinophilic disorders: 2005 update. Acta Haematol 2005;114(1):725.
5.Lee, NA, McGarry, MP, Larson, KA, et al. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol 1997;158(3):1332–44.
6.Dent, LA, Strath, M, Mellor, AL, Sanderson, CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172(5):1425–31.
7.Rennick, DM, Thompson, -Snipes, L, Coffinan, RL, et al. In vivo administration of antibody to interleukin-5 inhibits increased generation of eosinophils and their progenitors in bone marrow of parasitized mice. Blood 1990; 76(2):312–16.
8.Sher, A, Coffman, RL, Hieny, S, et al. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA 1990;87(1):61–5.
9.Lu, L, Lin, ZN, Shen, RN, et al. Influence of interleukins 3,5, and 6 on the growth of eosinophil progenitors in highly enriched human bone marrow in the absence of serum. Exp Hematol 1990;18(11):1180–6.
10.Brugnoni, D, Airo, R, Rossi, G, et al. A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 1996;87(4):1416–22.
11.Okayama, H, Fushimi, T, Sllimura, S, et al. Glucocorticoids suppressed production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjects. J Allergy Clin Immunol 1994;93(6):1006–12.
12.Krishnaswamy, G, Smith, J, Srikandl, S, et al. Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines. J Interferon Cytokine Res 1996;16(10):819–27.
13.Walsh, GM, Hartnell, A, Wardlaw, AJ, et al. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71(2):258–65.
14.Medoff, HS, Barbero, GJ. Total blood eosinophil counts in the newborn period. Pediatrics 1950;6(5):737–42.
15.Xanthou, M. Leucocyte blood picture in ill newborn babies. Arch Dis Child 1972;47(255):741–6.
16.Burrell, JM. A comparative study of the circulating eosinophil level in babies. Part I. Premature infants. Arch Dis Child 1952;27(134):337–40.
17.Bass, DA. Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest 1975;56(4):870–9.
18.Gibson, EL, Vaucher, Y, Corrigan, JJ Jr. Eosinophilia in premature infants: Relationship to weight gain. J Pediatr 1979;95(1):99101.
19.Portuguezmalavasi, A, Coteboileau, T, Aranda, JV. Eosinophilia in the newborn, possible role in adverse drug-reactions. Pediatrc Res 1980;14(4):537–8.
20.Craver, RD. The cytology of cerebrospinal fluid associated with neonatal intraventricular hemorrhage. Pediatr Pathol Lab Med 1996;16(5):713–19.
21.Patel, L, Garvey, B, Arnon, S, Roberts, IA. Eosinophilia in newborn infants. Acta Paediatr 1994;83(8):797801.
22.Odelram, H, Bjorksten, B, Leander, E, Kjellman, NI. Predictors of atopy in newborn babies. Allergy 1995;50(7):585–92.
23.Yamamoto, C, Kojima, T, Hatrori, K, et al. Eosinophilia in premature infants: Correlation with chronic lung disease. Acta Paediatrica 1996;85(10):1232–5.
24.Morgan, AJ, Steen, CJ, Schwartz, RA, Janniger, CK. Erythema toxicum neonatorum revisited. Cutis 2009;83(1):13–16.
25.Matsumoto, K, Shimanouchi, Y, Kawakubo, K, et al. Infantile eczema at one month of age is associated with cord blood eosinophilia and subsequent development of atopic dermatitis and wheezing illness until two years of age. Int Arch Allergy Immunol 2005;137 Suppl 1:6976.
26.Marchini, G, Ulfgren, AK, Loré, K, et al. Erythema toxicum neonatorum: An immunohistochemical analysis. Pediatr Dermatol 2001;18(3):177–87.
27.Ladrigan, MK, LeBoit, PE, Frieden, IJ. Neonatal eosinophilic pustulosis in a 2-month old. Pediatr Dermatol 2008;25(1):52–5.
28.Asgari, M, Leiferman, KM, Piepkorn, M, Kuechle, MK. Neonatal eosinophilic pustulosis. Int J Dermatol 2006;45(2):131–4.
29.Chiang, YC, Shyur, SD, Huang, LH, et al. Chlamydia trachomatis pneumonia: Experience in a medical center. Acta Paediatr Taiwan 2005;46(5):284–8.
30.Lindemans, CA, Kimpen, JL, Luijk, B, et al. Systemic eosinophil response induced by respiratory syncytial virus. Clin Exp Immunol 2006;144(3):409–17.
31.Brostrom, EB, Katz, -Salamon, M, Lundahl, J, Halldén, G, Winbladh, B. Eosinophil activation in preterm infants with lung disease. Acta Paediatr, 2007;96(1):23–8.
32.Pentiuk, SP, Miller, CK, Kaul, A. Eosinophilic esophagitis in infants and toddlers. Dysphagia 2007;22(1):44–8.
33.Ohtsuka, Y, Shimizu, T, Shoji, H, et al. Neonatal transient eosinophilic colitis causes lower gastrointestinal bleeding in early infancy. J Pediatr Gastroenterol Nutr 2007;44(4):501–5.
34.Tajirian, A, Ross, R, Zeikus, P, Robinson, -Bostom, L. Subcutaneous fat necrosis of the newborn with eosinophilic granules. J Cutan Pathol 2007;34(7):588–90.
35.Juul, SE, Haynes, JW, McPherson, RJ. Evaluation of eosinophilia in hospitalized preterm infants. J Perinatol 2005;25(3):182–8.
36.Carballo, C, Foucar, K, Swanson, P, Papile, LA, Watterberg, KL. Effect of high altitude on neutrophil counts in newborn infants. J Pediatr 1991;119(3):464–6.
37.Maynard, EC, Reed, C, Kircher, T. Neutrophil counts in newborn infants at high altitude. J Pediatr 1993;122(6):990–1.
38.Schmutz, N, Henry, E, Jopling, J, Christensen, RD. Expected ranges for blood neutrophil concentrations of neonates: The Manroe and Mouzinho charts revisited. J Perinatol 2008;28(4):275–81.
39.Manroe, BL, Weinberg, AG, Rosenfeld, CR, Browne, R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979;95(1):8998.
40.Mouzinho, A, Rosenfeld, CR, Sanchez, PJ, Risser, R. Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics 1994;94(1):7682.
41.Manroe, BL. Neutrophil values in infants born at high altitudes. J Pediatr 1992;120(2 Pt 1):334–5.
42.Xanthou, M. Leucocyte blood picture in healthy full-term and premature babies during neonatal period. Arch Dis Child 1970;45(240):242–9.
43.Newman, TB, Puopolo, KM, Wi, S, Draper, D, Escobar, GJ. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010; 126(5):903–9.
44.Hornik, CP, Benjamin, DK, Becker, KC, et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J 2012;31(8):803–7.
45.Rastogi, S, Rastogi, D, Sundaram, R, Kulpa, J, Parekh, AJ. Leukemoid reaction in extremely low-birth-weight infants. Am J Perinatol 1999;16(2):93–7 .
46.Krumbhaar, EB. Leukemoid blood pictures in various clinical conditions. Am J Med Sci 1926;172(4):519–32.
47.Calhoun, DA, Kirk, JF, Christensen, RD. Incidence, significance, and kinetic mechanism responsible for leukemoid reactions in patients in the neonatal intensive care unit: a prospective evaluation. J Pediatr 1996;129(3):403–9.
48.Zanardo, V, Savio, V, Giacomin, C, et al. Relationship between neonatal leukemoid reaction and bronchopulmonary dysplasia in low-birth-weight infants: a cross-sectional study. Am J Perinatol 2002;19(7):379–86.
49.Hsiao, R, Omar, SA. Outcome of extremely low birth weight infants with leukemoid reaction. Pediatrics 2005;116(1):e43-e51.
50.Zanardo, V, Vedovato, S, Trevisanuto, DD, et al. Histological chorioamnionitis and neonatal leukemoid reaction in low-birth-weight infants. Hum Pathol 2006;37(1):8791.
51.Henry, E, Walker, D, Wiedmeier, SE, Christensen, RD. Hematological abnormalities during the first week of life among neonates with Down syndrome: Data from a multihospital healthcare system. Am J Med Genet A 2007;143A(1):4250.
52.Nijhawan, A, Baselga, E, Gonzalez, -Ensenat, MA, et al. Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders. Arch Dermatol 2001;137(6):760–3.
53.Burch, JM, Weston, WL, Rogers, M, Morelli, JG. Cutaneous pustular leukemoid reactions in trisomy 21. Pediatr Dermatol 2003;20(3):232–7.
54.Xu, G, Nagano, M, Kanezaki, R, et al. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. Blood 2003;102(8):2960–8.
55.Crispino, JD. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 2005;16(1):137–47.
56.Engmann, C, Donn, SM. Severe neutrophilia in an infant with persistent pulmonary hypertension of the newborn. Am J Perinatol 2003;20(7):347–51.
57.Alizadeh, P, Rahbarimanesh, AA, Bahram, MG, Salmasian, H. Leukocyte adhesion deficiency type 1 presenting as leukemoid reaction. Indian J Pediatr 2007;74(12):1121–3.
58.Lambert, RM, Baer, VL, Wiedmeier, SE, et al. Isolated elevated blood neutrophil concentration at altitude does not require NICU admission if appropriate reference ranges are used. J Perinatol 2009;29(12):822–5.
59.Wiedmeier, SE, Henry, E, Christensen, RD. Hematological abnormalities during the first week of life among neonates with trisomy 18 and trisomy 13: Data from a multi-hospital healthcare system. Am J Med Genet A 2008;146A(3):312–20.
60.Brazy, JE, Grimm, JK, Little, VA. Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J Pediatr 1982;100(2):265–71
61.Koenig, JM, Christensen, RD. Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Engl J Med 1989;321(9):557–62.
62.Koenig, JM, Christensen, RD. The mechanism responsible for diminished neutrophil production in neonates delivered of women with pregnancy-induced hypertension. Am J Obstet Gynecol 1991;165(2):467–73.
63.Doron, MW, Makhlouf, RA, Katz, VL, et al. Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia. J Pediatr 1994;125(3):452–8.
64.Cadnapaphornchai, M, Faix, RG. Increased nosocomial infection in neutropenic low birth weight (2000 grams or less) infants of hypertensive mothers. J Pediatr 1992;121(6): 956–61.
65.Koenig, JM, Hunter, DD, Christensen, RD. Neutropenia in donor (anemic) twins involved in the twin-twin transfusion syndrome. J Perinatol 1991;11(4):355–8.
66.Koenig, JM, Christensen, RD. Neutropenia and thrombocytopenia in infants with Rh hemolytic disease. J Pediatr 1989;114(4 Pt 1):625–31.
67.Zook, KJ, Mackley, AB, Kern, J, Paul, DA. Hematologic effects of placental pathology on very low birthweight infants born to mothers with preeclampsia. J Perinatol 2009;29(1):812.
68.Guner, S, Yigit, S, Cetin, M, et al. Evaluation of serum granulocyte colony stimulating factor levels in infants of preeclamptic mothers. Turk J Pediatr 2007;49(1):5560.
69.Tsao, PN, Teng, R-J, Tang, J-R, Yau, K-I T. Granulocyte colony-stimulating factor in the cord blood of premature neonates born to mothers with pregnancy-induced hypertension. J Pediatr 1999;135(1):56–9.
70.Manzoni, P, Farina, D, Monetti, C, et al. Early-onset neutropenia is a risk factor for Candida colonization in very low-birth-weight neonates. Diagn Microbiol Infect Dis 2007;57(1):7783.
71.Teng, RJ, Wu, TJ, Garrison, RD, Sharma, R, Huday, ML. Early neutropenia is not associated with an increased rate of nosocomial infection in very low-birth-weight infants. J Perinatol 2009;29(3):219–24.
72.Ahmad, M, Fleit, HB, Golightly, MG, LaGamma, EF. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates. Biol Neonate 2004;86(1):4854.
73.Zuppa, AA, Girlando, P, Florio, MG, et al. Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor effect in neutropenic neonates with suspected sepsis. Eur J Obstet Gynecol Reprod Biol 2002;102(2):131–6.
74.Kocherlakota, P, La Gamma, EF. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia. Pediatrics 1998;102(5):1107–11.
75.Shankaran, S, Pappas, A, Laptook, AR, et al. Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy. Pediatrics 2008;122(4):e791–8.
76.Azzopardi, DV, Strohm, B, Edwards, AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009;361(14):1349–58.
77.Jacobs, SE, Morley, CJ, Inder, TE, et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: A randomized controlled trial. Arch Pediatr Adolesc Med 2011;165(8):692700.
78.Simbruner, G, Mittal, RA, Rohlmann, F, et al. Systemic hypothermia after neonatal encephalopathy: Outcomes of neo.nEURO.network RCT. Pediatrics 2010;126(4):e771–8.
79.Jenkins, DD, Lee, T, Chiuzan, C, et al. Altered circulating leukocytes and their chemokines in a clinical trial of therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy*. Pediatr Crit Care Med 2013;14(8):786–95
80.Cybulsky, MI, Movat, HZ. Experimental bacterial pneumonia in rabbits: Polymorphonuclear leukocyte margination and sequestration in rabbit lungs and quantitation and kinetics of 51Cr-labeled polymorphonuclear leukocytes in E. coli-induced lung lesions. Exp Lung Res 1982;4(1):4766.
81.Erdman, SH, Christensen, RD, Bradley, PP, Rothstein, G. Supply and release of storage neutrophils. A developmental study. Biol Neonate 1982;41(3–4):132–7
82.Christensen, RD, Rothstein, G. Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 1980;96(2):316–18.
83.Christensen, RD. Neutrophil kinetics in the fetus and neonate. Am J Pediatr Hematol Oncol 1989;11(2):215–23.
84.al-Mulla, ZS, Christensen, RD. Neutropenia in the neonate. Clin Perinatol 1995;22(3):711–39.
85.Rodwell, RL, Taylor, K, Tudehope, D, Gray, P. Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns. Pediatr Infect Dis J 1993;12(5):372–6.
86.Carr, R. Neutrophil production and function in newborn infants. Br J Haematol 2000;110(1):1828.
87.Maheshwari, A, Christensen, RD. Developmental granulopoiesis. In Polin, RA, Fox, WW, Abman, SH, eds. Fetal and Neonatal Physiology (Philadelphia, PA: Saunders, 2004).
88.Boxer, LA, Yokoyama, M, Lalezari, P. Isoimmune neonatal neutropenia. J Pediatr 1972;80(5):783–7.
89.Lalezari, P, Radel, E. Neutrophil-specific antigens: Immunology and clinical significance. Semin Hematol 1974;11(3):281–90.
90.Levine, DH, Madyastha, PR. Isoimmune neonatal neutropenia. Am J Perinatol 1986;3(3):231–3.
91.Conway, LT, Clay, ME, Kline, WE, et al. Natural history of primary autoimmune neutropenia in infancy. Pediatrics 1987;79(5):728–33.
92.Lalezari, P, Khorshidi, M, Petrosova, M. Autoimmune neutropenia of infancy. J Pediatr 1986;109(5):764–9.
93.Veldhuisen, B, Porcelijn, L, Ellen van der Schoot, C, de Haas, M. Molecular typing of human platelet and neutrophil antigens (HPA and HNA). Transfus Apher Sci 2014;50(2):189–99.
94.Boxer, LA, Greenberg, MS, Boxer, GJ, Stossel, TP. Autoimmune neutropenia. N Engl J Med 1975;293(15):748–53.
95.Lyall, EG, Lucas, GF, Eden, OB. Autoimmune neutropenia of infancy. J Clin Pathol 1992;45(5):431–4.
96.Bux, J. Molecular nature of granulocyte antigens. Transfus Clin Biol 2001;8(3):242–7.
97.Farruggia, P. Immune neutropenias of infancy and childhood. World J Pediatr 2016;12(2):142–8.
98.Horwitz, M, Benson, K, Person, R, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999;23(4): 433–6.
99.Dale, DC, Person, RE, Bolyard, AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000;96(7):2317–22.
100.Beekman, R, Touw, IP. G-CSF and its receptor in myeloid malignancy. Blood 2010;115(25):5131–6.
101.Link, DC, Kunter, G, Kasai, Y, et al. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood 2007;110(5):1648–55.
102.Skokowa, J, Steinemann, D, Katsman, -Kuipers, JE, et al. Cooperativity of RUNX1 and CSF3 R mutations in severe congenital neutropenia: A unique pathway in myeloid leukemogenesis. Blood 2014;123(14): 2229–37.
103.Kostmann, R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl 1956;45(Suppl 105):178.
104.Bonilla, MA, Gillio, AP, Ruggeiro, M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320(24):1574–80.
105.Dale, DC, Bolyard, AA, Hammond, WP. Cyclic neutropenia: Natural history and effects of long-term treatment with recombinant human granulocyte colony-stimulating factor. Cancer Invest 1993;11(2):219–23.
106.Makaryan, V, Zeidler, C, Bolyard, AA, et al. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr Opin Hematol 2015;22(1):311.
107.Shwachman, H, Diamond, LK, Oski, FA, Khaw, KT. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 1964;65:645–63.
108.Burroughs, L, Woolfrey, A, Shimamura, A. Shwachman–Diamond syndrome: A review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am 2009;23(2):233–48.
109.Boocock, GR, Morrison, JA, Popovic, M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003;33(1):97101.
110.Ganapathi, KA, Austin, KM, Lee, CS, et al. The human Shwachman–Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood 2007;110(5):1458–65.
111.Rujkijyanont, P, Adams, S‐L, Beyene, J, Dror, Y. Bone marrow cells from patients with Shwachman–Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing. Br J Haematol 2009;145(6):806–15.
112.Roper, M, Parmley, RT, Crist, WM, Kelly, DR, Cooper, MD. Severe congenital leukopenia (reticular dysgenesis).Immunologic and morphologic characterizations of leukocytes. Am J Dis Child 1985;139(8):832–5.
113.Bertrand, Y, Müller, S, Casanova, J, et al. Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients. Bone Marrow Transplant 2002;29(9):759–62.
114.Christensen, RD, Henry, E, Wiedmeier, SE, Stoddard, RA, Lambert, DK. Low blood neutrophil concentrations among extremely low birth weight neonates: data from a multihospital health-care system. J Perinatol 2006;26(11):682–7.
115.Juul, SE, Calhoun, DA, Christensen, RD. “Idiopathic neutropenia” in very low birthweight infants. Acta Paediatr 1998;87(9):963–8.
116.Juul, SE, Christensen, RD. Effect of recombinant granulocyte colony-stimulating factor on blood neutrophil concentrations among patients with “idiopathic neonatal neutropenia”: A randomized, placebo-controlled trial. J Perinatol 2003;23(6):493–7.
117.Rivers, A, Slayton, WB. Congenital cytopenias and bone marrow failure syndromes. Semin Perinatol 2009;33(1):20–8.
118.Nittala, S, Subbarao, GC, Maheshwari, A. Evaluation of neutropenia and neutrophilia in preterm infants. J Matern Fetal Neonatal Med 2012;25(Suppl 5):100–3.
119.Corey, SJ, Wollman, MR, Deshpande, RV. Granulocyte colony-stimulating factor and congenital neutropenia–risk of leukemia? J Pediatr 1996;129(1):187–8.
120.Sullivan, SE, Calhoun, DA. Eosinophilia in the neonatal intensive care unit. Clin Perinatol 2000; 27(3): 603–22, vi.
121.Pammi, M, Brocklehurst, P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia. Cochrane Database Syst Rev 2011;10:CD003956.
122.Ohlsson, A, Lacy, JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev, 2004;1:CD000361.
123.Ohlsson, A, Lacy, JB. Intravenous immunoglobulin for suspected or proven infection in neonates. Cochrane Database Syst Rev, 2015;3:CD001239.
124.Inis Collaborative Group, Brocklehurst, P, Farrell, B, et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 2011;365(13):1201–11.